These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 14515016

  • 21. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V, Zingali RB, Guillin MC, Bon C, Jandrot-Perrus M.
    Biochemistry; 1996 Jul 16; 35(28):9083-9. PubMed ID: 8703912
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.
    Lunven C, Gauffeny C, Lecoffre C, O'Brien DP, Roome NO, Berry CN.
    Thromb Haemost; 1996 Jan 16; 75(1):154-60. PubMed ID: 8713795
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE, Feijge MA, Lancé MD, Hamulyák K, ten Cate H, Heemskerk JW, van Pampus EC.
    Transfusion; 2008 Nov 16; 48(11):2384-94. PubMed ID: 18673348
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA, Cerskus AL, Hirsh J, Smith LM, Modi GJ, Blajchman MA.
    Br J Haematol; 1984 Jun 16; 57(2):229-38. PubMed ID: 6733045
    [Abstract] [Full Text] [Related]

  • 28. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
    Bendayan P, Boccalon H, Dupouy D, Boneu B.
    Thromb Haemost; 1994 May 16; 71(5):576-80. PubMed ID: 8091383
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ, Eisenberg PR, Abendschein DR.
    Blood Coagul Fibrinolysis; 1993 Feb 16; 4(1):7-13. PubMed ID: 8457655
    [Abstract] [Full Text] [Related]

  • 31. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H.
    Scand J Haematol; 1973 Feb 16; 10(4):291-7. PubMed ID: 4764611
    [No Abstract] [Full Text] [Related]

  • 32. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA, Levine SP.
    J Clin Invest; 1980 Feb 16; 65(2):307-13. PubMed ID: 6243308
    [Abstract] [Full Text] [Related]

  • 33. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.
    Mohri M, Sugimoto E, Sata M, Asano T.
    Thromb Haemost; 1999 Dec 16; 82(6):1687-93. PubMed ID: 10613656
    [Abstract] [Full Text] [Related]

  • 34. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S, Muntean W, Leis HJ.
    Thromb Haemost; 1995 Oct 16; 74(4):1163-8. PubMed ID: 8560429
    [Abstract] [Full Text] [Related]

  • 35. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G, Blombäck M, Olsson P, Riesenfeld J.
    Thromb Haemost; 1993 Aug 02; 70(2):289-93. PubMed ID: 8236137
    [Abstract] [Full Text] [Related]

  • 36. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E, Lunven C, Gauffeny C, Roome NO, Berry CN.
    Thromb Haemost; 1998 Nov 02; 80(5):840-4. PubMed ID: 9843181
    [Abstract] [Full Text] [Related]

  • 37. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP, Schullek JR, Hanel AM, MacAllan DR.
    Anal Biochem; 1999 May 15; 270(1):24-32. PubMed ID: 10328761
    [Abstract] [Full Text] [Related]

  • 38. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP, Castellani WJ, Hodges ED, Yelverton S.
    Thromb Haemost; 1991 Aug 01; 66(2):213-7. PubMed ID: 1771614
    [Abstract] [Full Text] [Related]

  • 39. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE, Kälsch T, Elmas E, Suvajac N, Lücke T, Münch E, Borggrefe M.
    Blood Coagul Fibrinolysis; 2008 Dec 01; 19(8):765-70. PubMed ID: 19002042
    [Abstract] [Full Text] [Related]

  • 40. [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
    Pastorova VE, Liapina LA, Cherkasova KA, Ashmarin IP.
    Usp Fiziol Nauk; 1999 Dec 01; 30(2):80-91. PubMed ID: 10420478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.